NEW

Siemens Healthineers to Acquire Varian

Siemens Healthineers AG and Varian Medical Systems Inc. have entered into an agreement, pursuant to which Siemens Healthineers shall acquire all shares of Varian for $177.50 per share in cash. This corresponds to a purchase price of approximately $16.4 billion....

MTMI Partners with Nautilus Medical Technologies

The Medical Technology Management Institute (MTMI), a division of The College of Health Care Professions, has announced a partnership with Nautilus Medical Technologies, developer of a cloud-based imaging sharing platform used by over a thousand health care providers...

Gillette Children’s Specialty Healthcare is the first U.S. hospital to image patients with EOSedge

EOS imaging, a provider of 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, has announced the first exams performed with EOSedge in the United States, at Gillette Children's Specialty Healthcare’s main campus...

Webinar on FDA’s Regulation of Face Masks and Surgical Masks during the COVID-19 Pandemic

On Tuesday, August 4, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the FDA’s regulation of face masks and surgical masks during the COVID-19 pandemic. This webinar will expand the scope of the respirator webinar series to...

Hutchinson Regional Medical Center Goes Live with Eon

Eon, a Denver-based healthtech leader, went live with Hutchinson Regional Medical Center as their lung cancer screening and incidental pulmonary nodule management solution in May 2020. Within the first week, the Kansas-based hospital experienced the positive—and potentially life-saving—benefits of the company’s Essential Patient Management (EPM) platform.

“The implementation of Eon has made an immediate impact on our patient management workflows. I am very excited about what Eon has brought to the table since the go-live on May 20th, 2020. Within just one week, we came across more than 10 (incidental pulmonary nodule) patients who are now scheduled, and may have been missed, if not for Eon,” said Raleigh White, Director of Imaging Services at Hutchinson.

The Eon EPM platform is an end-to-end patient management solution that uses Computational Linguistics—Eon’s best-in-class proprietary data science models—to partner with hospital systems to identify, track, and manage the most at-risk patients. The technology is a mission-critical solution that analyzes radiology reports to identify abnormalities and ensure patients at risk for lung cancer do not get lost in the system.

“I’m really lucky. I get to meet people across the country and help hospitals set up their lung cancer programs,” said Dr. Aki Alzubaidi, DO, FCCP, Eon founder and co-CEO. “As an Interventional Pulmonologist, I think about early intervention and desired results for lung cancer patients all of the time. It started in my own personal practice and now, through Eon, we are able to provide the same safety net and ensure longitudinal follow-up to facilities across the country.”

White adds, “We had extensive dialogue with another vendor and were told that all options were the same as those offered by Eon. When we compared apples to apples, the options were not the same as those offered by Eon.”

EPM is the only actionable findings patient management platform to positively identify incidental pulmonary nodules with over 97% precision. And in an industry where the standard for new software implementation can take anywhere from 6 months to several years, Eon pledges a “7-day Promise” to implement at record speed. In just seven days, EPM was up and running at Hutchinson.

“In 30 years as an imaging professional, this has never been my experience and is a first,” White said, adding that Eon’s speed and agility are unmatched in the industry.

Eon maintains its commitment to developing technology that challenges the status quo in healthcare and arming hospitals—like Hutchinson—with the tools they need to help patients fight catastrophic disease.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *